Haws R M, Shaul P W, Arant B S, Atiyeh B A, Seikaly M G
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.
Pediatr Res. 1994 Jun;35(6):671-6. doi: 10.1203/00006450-199406000-00010.
There is increasing evidence that an activated intrarenal renin-angiotensin system (RAS) alters renal hemodynamics and fluid balance and that such events may lead to the development of hypertension. To examine the role of the glomerular RAS in the development of hypertension in the spontaneously hypertensive (SHR) rat, we studied angiotensin (ANG) II receptors in isolated glomeruli from young (4- to 5-wk-old) and adult (10- to 12-wk-old) SHR and from age-matched, normotensive Wistar-Kyoto (WKY) rats. Glomerular ANG II receptor density in young SHR is 3-fold higher than in age-matched WKY rats (2033 +/- 154 versus 742 +/- 151 receptors/microns2; p < 0.05) and 1.5-fold higher than in adult SHR and WKY rats (1128 +/- 85 and 1198 +/- 181 receptors/microns2, respectively; p < 0.05). Additional studies demonstrated that the differences in receptor density are not related to disparity in receptor occupancy and that they are also independent of systemic ANG levels. Suppression of RAS by ANG converting enzyme inhibitors resulted in a 3-fold increase in receptor density in young SHR rats and a 4.5-fold increase in young WKY rats; receptor density remained greater in young SHR rats (5915 +/- 318 versus 3358 +/- 234 receptors/microns2, p < 0.05). Furthermore, competitive binding experiments using the nonpeptide ANG II antagonists losartan (AT1) and PD 123319 (AT2) indicate that the greater ANG II receptor density in the young SHR rats represents an increase in the number of a single population of AT1 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
越来越多的证据表明,激活的肾内肾素-血管紧张素系统(RAS)会改变肾血流动力学和液体平衡,且此类情况可能导致高血压的发生。为了研究肾小球RAS在自发性高血压(SHR)大鼠高血压发生中的作用,我们研究了来自年轻(4至5周龄)和成年(10至12周龄)SHR以及年龄匹配的正常血压Wistar-Kyoto(WKY)大鼠的分离肾小球中的血管紧张素(ANG)II受体。年轻SHR的肾小球ANG II受体密度比年龄匹配的WKY大鼠高3倍(分别为2033±154和742±151受体/μm²;p<0.05),比成年SHR和WKY大鼠高1.5倍(分别为1128±85和1198±181受体/μm²;p<0.05)。进一步的研究表明,受体密度的差异与受体占有率的差异无关,且也独立于全身ANG水平。用血管紧张素转换酶抑制剂抑制RAS后,年轻SHR大鼠的受体密度增加了3倍,年轻WKY大鼠增加了4.5倍;年轻SHR大鼠的受体密度仍然更高(5915±318与3358±234受体/μm²,p<0.05)。此外,使用非肽类ANG II拮抗剂氯沙坦(AT1)和PD 123319(AT2)的竞争性结合实验表明,年轻SHR大鼠中更高的ANG II受体密度代表单一AT1受体群体数量的增加。(摘要截断于250字)